Ranked in 1 Practice Areas
U

Up and Coming

Life Sciences

Japan

2 Years Ranked

About

Provided by Takamasa Horio

Asia-Pacific

Practice Areas

Life Sciences, Crisis Management, Mergers and Acquisitions, General Corporate.

Career

Joined Mori Hamada & Matsumoto in 2010, becoming Partner in 2022. Worked with Jenner & Block LLP, Chicago (2016-2017). Seconded to the Pharmaceutical Safety and Environmental Health Bureau (Compliance and Narcotics Division, Pharmaceutical Evaluation Division, and Medical Device Evaluation Division) of the Ministry of Health, Labour and Welfare (2017-2020).

Professional Memberships

Admitted in Japan, 2009; Illinois, 2016.

Member of Review Committee for Study Regarding Pharmaceutical Regulations on Medical Equipment Programs Utilizing Artificial Intelligence and Other Advanced Technology, Japan Agency for Medical Research and Development (2020-); Member of Study Group on Countermeasures against Cannabis and Other Drugs, Ministry of Health, Labour and Welfare(2020-); Member of the Advisory Committee (Advisory Committee on Manufacture and Quality Control of Pharmaceutical Products) for Toyama Pharmaceutical Affairs Council (2021-), Member of the Toyama Prefecture GMP Inspection Investigative Committee (2021-); Member of Research for Identifying Issues Relating to Determinations on Whether Programs Constitute Medical Devices Based on International Consistency, a Special Scientific Research Project Sponsored by the MHLW (2021-); Adviser for The Japan Federation of Medical Devices Associations (2021-); Member of Legislation Committee, Japan Pharmaceutical Association (2022-).

Publications

“Legal Commentary: the Pharmaceuticals and Medical Devices Act”, Shojihomu, 2021; “Q&A: Digital Health and Law [2nd ed.]”, Shojihomu, 2022; "Case Studies and Key Points for Entry to the Health Care Industry by Companies of Different Business Categories (Part 1-8), Business Houmu, 2022-2023; “ Practical Responses Based on the Revised Pharmaceuticals and Medical Devices Act (Enforcement Date: August 1, 2021) (1), (2)”, NBL, 2021.

Personal

Graduated from Kyoto University Law School (J.D., 2008), Northwestern University Pritzker School of Law (LL.M., 2016) and Kellogg School of Management (Certificate in Business Administration, 2016).

Chambers Review

Provided by Chambers

Asia-Pacific

Life Sciences - Japan
U
Up and Coming

Takamasa Horio is an up-and-coming lawyer assisting pharmaceutical and medical device companies with regulatory matters. Clients benefit from his experience working as part of government bodies in the life sciences space.

Contributions

Latest contributions provided by Takamasa Horio

Global Practice Guide
Takamasa Horio
Yasutaka Tokuda
Mizuho Yoshida
Karin Omata
Authored by
Takamasa Horio, Yasutaka Tokuda, Mizuho Yoshida, Karin Omata
Article • May 2024

Strengths

Provided by Chambers

Discover other Lawyers at
Mori Hamada & Matsumoto

Provided by Chambers
Filter by
Band

Japan

Banking & Finance: Domestic

Hiroki Aoyama
1
Hiroki Aoyama
1
Band 1
1
Masanori Sato
1
Band 1
Takahiro Kobayashi
3
Takahiro Kobayashi
3
Band 3
Yuki Matsuda
U
Yuki Matsuda
U
Up and Coming
Yusuke Suehiro
U
Yusuke Suehiro
U
Up and Coming
Capital Markets: Domestic

Katsumasa Suzuki
1
Katsumasa Suzuki
Head of Capital Markets: Domestic
1
Band 1
Taro Omoto
2
Taro Omoto
2
Band 2
Toshimitsu Nemoto
2
Toshimitsu Nemoto
2
Band 2
Katsuyuki Tainaka
4
Katsuyuki Tainaka
4
Band 4
Capital Markets: Domestic: J-REITs

Taro Omoto
2
Taro Omoto
2
Band 2
3
Yasuhiko Fujitsu
3
Band 3
Capital Markets: Domestic: Securitisation & Derivatives

Akira Ehira
1
Akira Ehira
1
Band 1
1
Masanori Sato
1
Band 1
Competition/Antitrust

Kenji Ito
1
Kenji Ito
1
Band 1
2
Hideki Utsunomiya
2
Band 2
Yusuke Takamiya
4
Yusuke Takamiya
4
Band 4
Corporate/M&A: Domestic

Gaku Ishiwata
1
Gaku Ishiwata
Head of Corporate/M&A: Domestic
1
Band 1
1
Hajime Tanahashi
Head of Corporate/M&A: Domestic
1
Band 1
Atsushi Oishi
4
Atsushi Oishi
4
Band 4
Hirokazu Hayashi
4
Hirokazu Hayashi
4
Band 4
20 of 67 results